Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 4 Option exercise Director acquired 2,500 shares (option exercise)
  2. 8-K Event Shareholder vote results
  3. ARS Other Annual Report to Security Holders
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. DEF 14A Proxy Proxy Statement
  8. 4 Open-market sale PAO sold 182 shares at $12.25 ($2,230)
  9. 4 Open-market sale EVP, CMO sold 1,250 shares at $12.25 ($15,313)
  10. 4 Open-market sale President and CEO sold 4,634 shares at $12.25 ($56,767)
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 38 of 68 · 1,358 filings